PLX4032, a selective BRAF <sup>V600E</sup> kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF <sup>WT</sup> melanoma cellsRuth Halaban, Mario Sznol|Pigment Cell & Melanoma Research|2010Cited by 322
Integrative Analysis of Epigenetic Modulation in Melanoma Cell Response to Decitabine: Clinical ImplicationsRuth Halaban, Jan J. Enghild|PLoS ONE|2009Cited by 58